Trivandrum, India, which was a joint public/private venture with the Indian Ministry of Health and funded by UNFPA and USAID.  By the time J&J’s Ortho division acquired GynoPharma, FEI had expanded sales and distribution of the company’s contraceptive products into over 100 countries and was the world’s largest IUD manufacturer.  While running FEI, Pike also formed Akcess Medical Co. and Enhance Pharmaceuticals.  Akcess developed and commercialized the first dual fistula needle for dialysis patients and Enhance developed a silicone sylastic vaginal drug delivery ring; these two assets were acquired by Horizon Medical and Barr Laboratories, respectively.  Over the decade following his purchase of FEI, Pike realized a return exceeding $100 million on his initial $1.1 million investment for FEI.